Evidence map›Paper›PMID 30290606›Full record

ReviewMedicine2018

Phosphaturic mesenchymal tumor and related wound problem.

Xian Xiao, Xiaofang Sun, Pengwen Ni, Yao Huang, Ting Xie

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Phosphaturic mesenchymal tumor: Case report.Radiology case reports · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Xian XiaoShanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai.
Xiaofang SunDepartment of Dermatology, The Second Hospital Affiliated to Jiaxing University, Jiaxing, Zhejiang, China.
Pengwen NiShanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai.
Yao HuangShanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai.
Ting XieShanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai.
Shanghai Jiao Tong University · CNShanghai Ninth People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionPhosphaturic mesenchymal tumor mixed connective tissue type (PMT/MCT) is the most common type (up to 90%) of phosphaturic mesenchymal tumor (PMT), a rare clinicopathologic entity. Besides overproduction of fibroblast growth factor 23 (FGF23), there is a big variation of immunohistochemical characteristic across types of PMT, which makes it difficult to obtain an early diagnosis of PMT/MCT. As a benign tumor, PMT/MCT usually happens in subcutaneous tissues and leads to nonhealing of wound. A complete excision of PMT/MCT facilitates wound healing.

conclusionsReview of the existing evidence indicates that early diagnosis of PMT/MCT is critically important when treating PMT/MCT wound. Hence standardization of early diagnosis for PMT/MCT is mandated.

Indexed as

Biomarkers, TumorDiagnosis, DifferentialEarly Detection of CancerFibroblast Growth Factor-23Fibroblast Growth FactorsHumansHypophosphatemia, FamilialMesenchymomaMixed Connective Tissue DiseaseSoft Tissue NeoplasmsWounds and InjuriesBiomarkers, TumorFGF23 protein, humanFibroblast Growth Factor-23Fibroblast Growth Factors

Identifiers

PMID30290606
PMCPMC6200523
OpenAlexW2895149816

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.